Safety and In-Hospital Outcomes of Bivalirudin Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention
December 23rd, 2009 Posted by: admin
Publication year: 2009
Source: The American Journal of Cardiology, In Press, Corrected Proof, Available online 22 December 2009
Cedric, Delhaye , Gabriel, Maluenda , Kohei, Wakabayashi , Itsik, Ben-Dor , Sara D., Collins , …
Chronic dialysis-dependent patients undergoing percutaneous coronary intervention (PCI) are at a greater risk of bleeding and ischemic events. Bivalirudin has been associated with fewer bleeding complications than unfractionated heparin (UFH) in patients undergoing PCI in various clinical settings. These studies, however, have systematically excluded patients dependent on chronic dialysis. We sought to assess the safety, bleeding rates, and in-hospital outcomes of bivalirudin use compared to UFH use alone in patients requiring dialysis and undergoing PCI. A retrospective analysis of 396 dialysis-dependent patients undergoing PCI from January 2000 to March 2009 was performed. Patients treated with a dose-adjusted bivalirudin regimen (n…
Similar Posts:
- Comparison of Bivalirudin and Unfractionated Heparin Plus Protamine in Patients With Coronary Heart Disease Undergoing Percutaneous Coronary Intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] Trial)
- Bleeding After Percutaneous Coronary Intervention With Bivalirudin or Unfractionated Heparin and One-Year Mortality
- Comparison of Bivalirudin Monotherapy Versus Unfractionated Heparin Plus Tirofiban in Patients With Diabetes Mellitus Undergoing Elective Percutaneous Coronary Intervention
- Long-term outcome on renal replacement therapy in patients who previously received a keto acid-supplemented very-low-protein diet.
- Relation of Platelet Count to Bleeding and Vascular Complications in Patients Undergoing Coronary Angiography
- Six-Month Follow-Up of Patients With In-Hospital Thrombocytopenia During Heparin-Based Anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] Registry)
- Comparison of Prolonged Bivalirudin Infusion Versus Intraprocedural in Preventing Myocardial Damage After Percutaneous Coronary Intervention in Patients With Angina Pectoris
- ACC: Adjunctive Med May Fight Stent Thrombosis on Bivalirudin (CME/CE, with video)
- Effect of high-normal compared with low-normal arterial pH on protein balances in automated peritoneal dialysis patients.
- Relation of Race (Asian, African-American, European-American, and Hispanic) to Activated Clotting Time After Weight-Adjusted Bolus of Heparin During Percutaneous Coronary Intervention